Oridonin, an AKT1 Inhibitor, Suppresses the Growth of Breast Cancers with Hyperactivation of PI3K/AKT Signaling
E3S Web Conf., 271 (2021) 03014
Published online: 15 June 2021
DOI: 10.1051/e3sconf/202127103014